Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Competing Interests Professor Melanie Davies has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Abbvie, Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma Regeneron, GSK and EktaH and as a speaker for AstraZeneca and Boehringer Ingelheim
Criteria for considering studies for this review Types of studies We aimed to gather present evidence that investigates the role of GLP-1 receptor agonists in PD patients
A.ColomboA
Therefore, which one you choose will be based on your preferences, tolerance, and recommendation by your healthcare provider.
US$ 20.11
US$ 21.53
US$ 26.07
US$ 24.25
US$ 23.25
US$ 25.01
US$ 22.97
US$ 23.09
